Automated Multiparameter Flow Cytometry (MFC) Immunophenotyping for Reproducible Identification of High Risk Smoldering Multiple Myeloma (SMM)

被引：0

作者：

Paiva, Bruno ^{[1
]}

Johnson, Sarah K. ^{[2
]}

Mateos, Maria-Victoria ^{[3
]}

Alapat, Daisy V. ^{[4
]}

Puig, Noemi ^{[5
]}

Hernandez, Miguel-T ^{[6
]}

Escalante, Fernando ^{[7
]}

de Coca, Alfonso Garcia ^{[8
]}

Blade, Joan ^{[9
]}

Lahuerta, Juan Jose ^{[10
]}

Lecrevisse, Quentin ^{[11
]}

van Dongen, Jacques J. M. ^{[12
]}

Orfao, Alberto ^{[13
]}

Morgan, Gareth J. ^{[2
]}

Barlogie, Bart ^{[14
]}

San Miguel, Jesus ^{[15
]}

机构：

[1] Univ Navarra, Clin Univ Navarra, Ctr Invest Med Aplicada, Pamplona, Spain

[2] Univ Arkansas Med Sci, Myeloma Inst, Little Rock, AR USA

[3] Univ Salamanca, CSIC, IBMCC, Salamanca, Spain

[4] Univ Arkansas Med Sci, Dept Pathol, Little Rock, AR USA

[5] Hosp Univ Salamanca, Dept Hematol, Salamanca, Spain

[6] Hosp Univ Canarias, Tenerife, Spain

[7] Hosp Leon, Leon, Spain

[8] Hosp Clin Univ Valladolid, Valladolid, Spain

[9] Univ Barcelona, IDIBAPS, Hosp Clin Barcelona, Servei Hematol, Barcelona, Spain

[10] Hosp 12 Octubre, Madrid, Spain

[11] Univ Salamanca, Salamanca, Spain

[12] Erasmus MC, Dept Immunol, Lab Med Immunol, Rotterdam, Netherlands

[13] Univ Salamanca, CIC, IBMCC USAL CSIC, Serv Gen Citometria, Salamanca, Spain

[14] Icahn Sch Med Mt Sinai, Hematol & Med Oncol, New York, NY USA

[15] CIMA UNAV IDISNA, Pamplona, Spain

来源：

BLOOD | 2016年 / 128卷 / 22期

关键词：

D O I：

10.1182/blood.V128.22.373.373

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

373

引用

页数：5

共 50 条

[21] Understanding high-risk smoldering multiple myeloma
Kreiniz, Natalia
Gertz, Morie A.
LEUKEMIA & LYMPHOMA, 2023, 64 (08) : 1361 - 1372
[22] New criteria to identify risk of progression in monoclonal gammopathy of uncertain significance and smoldering multiple myeloma based on multiparameter flow cytometry analysis of bone marrow plasma cells
Perez-Persona, Ernesto
Vidriales, Maria-Belen
Mateo, Gema
Garcia-Sanz, Ramon
Mateos, Maria-Victoria
de Coca, Alfonso Garcia
Galende, Josefina
Martin-Nunez, Guillermo
Alonso, Jose M.
de las Heras, Natalia
Hernandez, Jose M.
Martin, Alejandro
Lopez-Berges, Consuelo
Orfao, Alberto
San Miguel, Jesus F.
BLOOD, 2007, 110 (07) : 2586 - 2592
[23] Quantification of circulating clonal plasma cells via multiparametric flow cytometry identifies patients with smoldering multiple myeloma at high risk of progression
W I Gonsalves
S V Rajkumar
A Dispenzieri
D Dingli
M M Timm
W G Morice
M Q Lacy
F K Buadi
R S Go
N Leung
P Kapoor
S R Hayman
J A Lust
S J Russell
S R Zeldenrust
L Hwa
T V Kourelis
R A Kyle
M A Gertz
S K Kumar
Leukemia, 2017, 31 : 130 - 135
[24] Quantification of circulating clonal plasma cells via multiparametric flow cytometry identifies patients with smoldering multiple myeloma at high risk of progression
Gonsalves, W. I.
Rajkumar, S. V.
Dispenzieri, A.
Dingli, D.
Timm, M. M.
Morice, W. G.
Lacy, M. Q.
Buadi, F. K.
Go, R. S.
Leung, N.
Kapoor, P.
Hayman, S. R.
Lust, J. A.
Russell, S. J.
Zeldenrust, S. R.
Hwa, L.
Kourelis, T. V.
Kyle, R. A.
Gertz, M. A.
Kumar, S. K.
LEUKEMIA, 2017, 31 (01) : 130 - 135
[25] Multiparameter Flow Cytometry Identification of Neoplastic Subclones: A New Biomarker in Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma
Tarin, Fabian
Lopez-Castano, Francisco
Garcia-Hernandez, Carmen
Beneit, Paola
Sarmiento, Hector
Manresa, Pablo
Alda, Olga
Villarrubia, Blanca
Blanes, Margarita
Bernabeu, Javier
Amoros, Carmen
Sanchez-Sanchez, Sara
Fernandez-Minano, Carmen
De Paz, Francisco
Verdu-Belmar, Jose
Marco, Pascual
Matutes, Estella
ACTA HAEMATOLOGICA, 2019, 141 (01) : 1 - 6
[26] Sensitivity of flow cytometry immunophenotyping compared with bone marrow morphology in diagnosis of multiple myeloma
Yousof, Eman A.
Ahmed, Eman H.
Mansor, Shima G.
Mohamed, Hanan O.
Thabet, Ahmad F.
Sayed, Douaa M.
EGYPTIAN JOURNAL OF HAEMATOLOGY, 2019, 44 (04): : 227 - 231
[27] Genomic analysis of high-risk smoldering multiple myeloma
Lopez-Corral, Lucia
Victoria Mateos, Maria
Corchete, Luis A.
Eugenia Sarasquete, Maria
de la Rubia, Javier
de Arriba, Felipe
Lahuerta, Juan-Jose
Garcia-Sanz, Ramon
San Miguel, Jesus F.
Gutierrez, Norma C.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (09): : 1439 - 1443
[28] Treatment should immediately be started in every patients with high risk smoldering myeloma (SMM): No - defending the NO position
Ludwig, H.
Oncology Research and Treatment, 2015, 38 : 28 - 29
[29] Updated risk stratification model for smoldering multiple myeloma (SMM) incorporating the revised IMWG diagnostic criteria.
San Miguel, Jesus
Mateos, Maria-Victoria
Gonzalez, Veronica
Dimopoulos, Meletios A.
Kastritis, Efstathios
Hajek, Roman
Rodriguez, Carlos Fernandez de Larrea
Morgan, Gareth John
Merlini, Giampaolo
Mangiacavalli, Silvia
Goldschmidt, Hartmut
Cavo, Michele
Kyriakou, Charalampia
Qi, Ming
Ukropec, Jon
Weiss, Brendan M.
Cameron, Chris
Rajkumar, S. Vincent
Durie, Brian G.
Kumar, Shaji
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[30] Trial in Progress: A Phase 2 Study of Linvoseltamab for the Treatment of High-Risk Smoldering Multiple Myeloma (LINKER-SMM1)
Rodriguez Otero, Paula
Mateos, Maria-Victoria
Aina, Oluwaseun
Sinha, Arijit
Steele, Andrew J.
Hazra, Anasuya
Lorenc, Karen Rodriguez
Kroog, Glenn S.
Sarkaria, Shawn M.
San Miguel, Jesus
BLOOD, 2023, 142

← 1 2 3 4 5 →